Patient presenting to the outpatient department with decreased appetite, epigastric acidity, bloating, and three to four episodes of morning diarrhea—what are the appropriate treatment options?

Treatment Approach for Decreased Appetite, Acidity, Bloating, and Morning Diarrhea

Start with H. pylori testing (stool antigen or breath test) and empirical proton pump inhibitor (PPI) therapy at the lowest effective dose, while advising regular aerobic exercise. 1

Initial Assessment and Red Flags

First, determine if urgent evaluation is needed. Check the patient's age and specific alarm features:

• Age ≥55 years with weight loss → urgent endoscopy required 1
• Age >40 years from high gastric cancer risk area or family history of gastro-oesophageal cancer → urgent endoscopy 1
• Age ≥60 years with abdominal pain and weight loss → urgent abdominal CT to exclude pancreatic cancer 1

If none of these apply, proceed with outpatient management.

Baseline Laboratory Testing

• Full blood count if patient is ≥55 years 1
• Coeliac serology because the patient has overlapping IBS-type symptoms (morning diarrhea) 1

First-Line Treatment Algorithm

Step 1: H. pylori Test and Treat Strategy

Perform non-invasive H. pylori testing using stool antigen or carbon-urea breath test (NOT serology, as specificity is lower) 1

• If H. pylori positive: Give eradication therapy (strong evidence of efficacy) 1

  • This addresses both dyspeptic symptoms and potential peptic ulcer disease
  • Adverse events are more common than placebo but treatment is highly efficacious 1
  • No need to confirm eradication unless patient has increased gastric cancer risk 1

• If H. pylori negative OR symptoms persist after eradication: Proceed to Step 2

Step 2: Empirical Acid Suppression

Initiate PPI therapy at the lowest dose that controls symptoms 1

• PPIs have strong evidence (high quality) for treating functional dyspepsia 1
• No dose-response relationship exists, so avoid unnecessarily high doses 1
• Well tolerated with minimal side effects 1
• Alternative: H2-receptor antagonists (weaker evidence but well tolerated) 1

Step 3: Lifestyle Modification

Advise regular aerobic exercise (strong recommendation despite very low quality evidence) 1

Avoid overly restrictive diets - there is insufficient evidence for specialized diets including low FODMAP in functional dyspepsia 1. The guidelines explicitly warn against dietary restriction that could lead to malnutrition 1.

Addressing the Morning Diarrhea Component

The morning diarrhea pattern (3-4 episodes) suggests possible overlap with IBS-diarrhea or other conditions:

• Consider bile acid malabsorption if diarrhea persists despite dyspepsia treatment 2
• Rule out microscopic colitis if patient is female, age ≥50, has nocturnal/watery diarrhea, or uses NSAIDs/PPIs/SSRIs/statins 3
• Exclude celiac disease with serology (already recommended above) 1

If Symptoms Persist After 4-8 Weeks

Second-Line Treatment Options

Tricyclic antidepressants (TCAs) as gut-brain neuromodulators 1

• Start amitriptyline 10 mg once daily at bedtime
• Titrate slowly to maximum 30-50 mg once daily
• Strong evidence (moderate quality) for efficacy 1
• Requires careful explanation that this treats nerve hypersensitivity, not depression
• Counsel about side effects (dry mouth, drowsiness, constipation)

Alternative prokinetics (if available in your region) 1

• Tegaserod has strongest evidence (moderate quality) 1
• Acotiamide, itopride, mosapride have weaker evidence (low quality) 1
• Many unavailable outside Asia/USA 1

Common Pitfalls to Avoid

1. Don't perform routine gastric emptying testing or 24-hour pH monitoring - not recommended for typical functional dyspepsia 1

2. Don't use H. pylori serology - lower specificity than stool antigen or breath testing 1

3. Don't over-endoscope - yield is extremely low in young patients without alarm features; endoscopy doesn't provide lasting reassurance 1, 3

4. Don't prescribe opioids for severe symptoms - explicitly contraindicated to minimize iatrogenic harm 1

When to Refer to Gastroenterology

Refer if:

• Diagnostic doubt exists
• Symptoms are severe or refractory to first-line treatments
• Patient requests specialist opinion 1

Ideal secondary care management includes: specialist clinic access, dietetic support, access to efficacious drugs, and gut-brain behavioral therapies 1

Treatment Timeline

• Initial trial: 4-8 weeks of PPI therapy 4
• If responsive: Stop treatment after 4-8 weeks; if symptoms recur, restart same treatment 4
• If non-responsive after 2-4 weeks: Consider changing drug class or dosing 4
• Before referral: Ensure H. pylori test-and-treat strategy completed 4